Pliant Therapeutics Inc reports results for the quarter ended in September - Earnings Summary

Pliant Therapeutics

08/11/2022 23:06

* Pliant Therapeutics Inc  PLRX.OQ  reported a quarterly
adjusted
loss of 65 cents​​ per share for the quarter ended in September.
The mean expectation of ten analysts for the quarter was for a
loss of 74 cents per share.
    * Revenue fell 8% to $1.48 million from a year ago; analysts
expected $1.59 million. 
    * Pliant Therapeutics Inc's reported EPS for the quarter was
a
loss of 65 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Pliant Therapeutics Inc shares had risen by 3.6% this
quarter and gained 60.4% so far this year.
    * The company reported a quarterly loss of $30.62 million.
    * Wall Street's median 12-month price target for Pliant
Therapeutics Inc is $40.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 11:06 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.74          -0.65          Beat
 Jun. 30 2022      -0.81          -0.82          Missed
 Mar. 31 2022      -0.75          -0.78          Missed
 Dec. 31 2021      -0.76          -0.68          Beat